Skip to content
NBDC Human Database

No datasets in the cart.

Go to the cart

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000313

Type of data
NGS (Target Capture)
Access criteria
Controlled-access (Type I)
Total data volume
208 GB
File formats
  • FASTQ
Research
hum0145
Date published
2020-09-28
Date modified
2020-11-18
DDBJ Search
JGAD000313 (opens in a new tab)
JGA Study
JGAS000222 (opens in a new tab)

Analysis method

Targeted DNA sequencing

Materials and participants
Colorectal cancer (ICD10: C189): 10 cases (36 samples)
- Primary tumor tissues obtained by endoscopic biopsy prior to NAC: 10 cases (10 samples)
- Tumor tissues from resected specimens after NAC: 10 cases (10 samples)
- Non-tumor tissues from resected specimens after NAC: 10 cases (10 samples)
- Blood plasma: 3 cases (4 samples)
- Metastatic tumor tissues from resected specimens: 2 cases (2 samples)
  • Health status
    Mixed
  • Subject count
    36 (Sample)
Disease
Colorectal cancer (C189)
Sample description
DNAs extracted from tumor and matched non-tumor tissues from CRCs
  • Tissue
    Plasma
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
Targeted DNA sequencing
Target
ClearSeq Halo HS Cancer Research Panel
Reagent kit
HaloPlex Target Enrichment
SureSelect Target Enrichment System
Fragmentation
Enzymatic fragmentation
Platform
Illumina HiSeq 2500
Read type
Paired-end
Read length
100 bp
Data use policy
NBDC data sharing policy (JGAP000001)